Bronchoalveolar lavage

European Respiratory Monograph

Volumn 5, Issue 14, 2000, Pages 63-78

  Drent, M ^a   Jacobs, J A ^a   Wagenaar, Sj Sc ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bronchoalveolar lavage; Cellular analysis; Diagnostic procedure; Interstitial lung disease

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG INFECTION; LUNG LAVAGE; PROGNOSIS; REVIEW; SARCOIDOSIS;

EID: 0033815741     PISSN: 1025448X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Interstitial lung disease: A diagnostic approach. Are CT scan and lung biopsy indicated in every patient?
2. Diffuse lung disease: A view for the future
3. Diagnosis and management strategies for diffuse interstitial lung disease
4. Bronchoalveolar lavage
5. Bronchoalveolar lavage
6. Bronchoalveolar lavage as a research tool
7. Clinical guidelines and indications for bronchoalveolar lavage: Report of the European Society of Pneumonology Task Group on BAL
8. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosis sarcoidosis?
9. Successful treatment of diffuse lipoid pneumonitis with whole lung lavage
10. Bronchoalveolar lavage: Role in the pathogenesis, diagnosis, and management of interstitial lung disease
11. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups
12. Technical recommendations and guidelines for bronchoalveolar lavage (BAL)
13. Computer program using BALF analysis results as diagnostic tool in interstitial lung diseases
14. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
15. Prognostic value of bronchoalveolar lavage in sarcoidosis: The critical influence of disease presentation
16. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis
17. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis
18. Guidelines for measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL)
19. Sepsis syndrome and death after bronchoalveolar lavage
20. Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients. Bronchoalveolar lavage versus bronchial brushing
21. Diagnostic tests for pneumonia in ventilated patients: Prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard
22. Test characteristics of Acridine Orange, Gram and May-Grunwald Giemsa stains for enumeration of intracellular organisms in bronchoalveolar lavage fluid
23. Diagnosis of nosocomial pneumonia in mechanically ventilated patients: Repeatability of the bronchoalveolar lavage
24. Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: Usefulness of BAL fluid cytology
25. Sensitivity and specificity of BAL findings in sarcoidosis
26. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
27. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
28. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, non-Hodgkin's and Hodgkin's disease: An evaluation of differences
29. Drug-induced lung disease: 1990 Review
30. Drug-induced pulmonary disease. An Update
31. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis
32. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature
33. Amiodarone pulmonary toxicity. Dose and duration of treatment are not the only determinants of toxicity
34. Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid
35. The alveolitis of hypersensitivity pneumonitis
36. Bronchoalveolar lavage in extrinsic allergic alveolitis: Effect of time elapsed since antigen exposure
37. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis
38. Gold-induced pulmonary disease: Clinical features, outcome, and differentiation from rheumatoid lung disease
39. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation
40. The diagnosis of ventilator-associated pneumonia. A comparison of histologic, microbiologic, and clinical criteria
41. Immunopathology of collagen vascular disease
42. Interstitial lung disease in recent onset rheumatoid artritis
43. Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis
44. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP
45. Pulmonary infiltration associated with myelodysplasia
46. Bronchial manifestation of acute febrile neutrophilic dermatosis (Sweet's syndrome)
47. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils
48. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases
49. Mast cells in fibrotic lung disorders
50. BAL fluid LDH activity and LDH isoenzyme pattern in lipoid pneumonia caused by an intravenous injection of lamp oil
51. Interstitial pneumonitis and fibrosis associated with the inhalation of hair spray
52. Recurrent respiratory distress associated with carbamazepine overdose
53. Biological markers of acute lung injury: Prognostic and pathogenic significance
54. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage and inflammation
55. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats
56. Relationship between enzymatic markers of pulmonary cell damage and cellular profile: A study in bronchoalveolar lavage fluid
57. Diagnostic value of BALF cellular profile and enzymes in pulmonary disorders
58. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders
59. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica
60. Source of alkaline phosphatase activity in epithelial lining fluid of normal and injured F344 rat lungs
61. The association of man-made mineral fibre exposure and sarcoid like granulomas